ESR1 and breast carcinoma: Consistent with human breast cancer, ERα + Brpkp110 tumors are more immunologically “cold” compared to triple-negative E0771 tumors, with decreased intratumoral T cell infiltration and increased frequency of tumor-associated macrophages (TAM) (Fig. 1A–B).